Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Peter Kolchinsky, RA Capital Up Stake in Achillion Pharmaceuticals Even Higher

Peter Kolchinsky, Achillion Pharmaceuticals: This afternoon, Peter Kolchinsky and his hedge fund, RA Capital Management, strengthened their position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), a Form 4 filing with the SEC showed. RA Capital bought a total of some 2.4 million shares of the company via eight transactions at an average price of approximately $2.80 apiece. Following the acquisition of additional shares, RA now owns almost 19.3 million shares of Achillion.

Peter Kolchinsky

Disclosure: none

Recommended Reading:

Billionaire Ron Burkle Urges Morgans Hotel Group to Sell Itself…Again

Which Phone Warren Buffett Used In 2008 Could Have Changed History…But Probably Not

Ridgeback Capital Follows Steven Cohen Into Arrowhead Research